title: Monitoring of the free concentration of cyclosporine in plasma in man.
abstract: The free fraction of cyclosporine A (CsA) and its total plasma concentration as determined by HPLC(CsAT) were prospectively monitored in 66 recipients of renal transplants. The free CsA levels (CsAu) were calculated. The variability in free CsA levels was no less than for total CsAT levels. The correlation between CsAu and CsAT was high (r = 0.90). Both CsAT and CsAu covaried with serum triglycerides and apolipoprotein A1. Fourty-four of the 66 patients suffered acute rejection episodes on 69 occasions. CsAT and CSAu both decreased and to a similar extent at the occurrence of acute rejection (42% and 59% decrease, respectively; significant vs baseline. Not significant difference in decrease in CsAT vs CsAu). Acute nephrotoxicity occurred on 11 occasions in 10 patients. Both CsAT and CSAu were approximately twice as high at the time of acute nephrotoxicity as compared to one week previously. Both CsAT and CsAu were higher during the first month after transplantation in patients with than in patients without systemic infection. Thus, plasma CsAu gave no additional clinical information or guidance compared to CsAT in renal transplant recipients. Due to the complexity of its assay, which requires two consecutive analyses, there does not appear to be any need for routine monitoring of CsAu in renal transplant recipients.
authors.affiliation: Department of Clinical Pharmacology, Huddinge Hospital, Sweden.
authors.forename: A
authors.initials: A
authors.lastname: Lindholm
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002851:Chromatography, High Pressure Liquid; D003524:Cyclosporins / Q000009:adverse effects / Q000097:blood*; D004334:Drug Administration Schedule; D004347:Drug Interactions; D006084:Graft Rejection; D006801:Humans; D007239:Infections / Q000097:blood; D007674:Kidney Diseases / Q000139:chemically induced; D016030:Kidney Transplantation; D008074:Lipoproteins / Q000097:blood; D008875:Middle Aged; D011183:Postoperative Complications / Q000097:blood; D011446:Prospective Studies; D014280:Triglycerides / Q000097:blood
chemical_list: D003524:Cyclosporins; D008074:Lipoproteins; D014280:Triglycerides